BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 6406594)

  • 1. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
    Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM
    J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal process.
    Tzioufas AG; Costello R; Manoussakis MN; Papadopoulos NM; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():111-3. PubMed ID: 3109019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands.
    Moutsopoulos HM; Tzioufas AG; Bai MK; Papadopoulos NM; Papadimitriou CS
    Ann Rheum Dis; 1990 Nov; 49(11):929-31. PubMed ID: 2124096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.
    Rubin RL; Tang FL; Lucas AH; Spiegelberg HL; Tan EM
    J Immunol; 1986 Oct; 137(8):2522-7. PubMed ID: 3760565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistologically definable light chain restriction in autoimmune disease.
    Jasani B
    J Pathol; 1988 Jan; 154(1):1-5. PubMed ID: 3126283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal immunoglobulins in the serum of patients with primary Sjögren's syndrome.
    Youinou P; Papadopoulos NM; Katsikis P; Pennec YL; Jouquan J; Lelong A; Moutsopoulos HM
    Clin Exp Rheumatol; 1988; 6(3):247-52. PubMed ID: 3141095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome with anticentromere antibodies.
    Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
    Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sjögren's syndrome in relation to other autoimmune diseases.
    Feltkamp TE
    Neth J Med; 1992 Apr; 40(3-4):105-7. PubMed ID: 1603198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma in Sjögren's syndrome: urinary monoclonal free light chains as a diagnostic aid and a means of tumour monitoring.
    Walters MT; Stevenson FK; Herbert A; Cawley MI; Smith JL
    Scand J Rheumatol Suppl; 1986; 61():114-7. PubMed ID: 3109020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cryoglobulinemia in rheumatic diseases].
    Baranauskaĭte AA; Nasonov EL; Solov'ev SK
    Klin Med (Mosk); 1991 Jun; 69(6):23-32. PubMed ID: 1774903
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibody defined T cell subsets in primary and secondary Sjögren's syndrome.
    Fossaluzza V; Rossi P; Tosato F; Pirrone S; Tonutti E; Sala PG
    Boll Ist Sieroter Milan; 1986; 65(5):440-2. PubMed ID: 3493793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of light chain restriction in labial gland biopsies of Sjögren's syndrome detected by in situ hybridization.
    Jordan RC; Pringle JH; Speight PM
    J Pathol; 1995 Sep; 177(1):35-40. PubMed ID: 7472777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.